Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
home:diseases:cardiovascular [02.11.2019]
sallieq [Cardiovascular diseases]
home:diseases:cardiovascular [05.24.2019] (current)
sallieq [More information]
Line 251: Line 251:
 //**Jen Hicks**, MarshallProtocol.com//</​blockquote>​ //**Jen Hicks**, MarshallProtocol.com//</​blockquote>​
 ===== More information ===== ===== More information =====
 +
 +Hyperuricaemia was associated with an unfavourable cardiovascular risk profile in HF patients. Treatment with low doses of allopurinol did not improve the prognosis of HF patients. ​ (({{pubmed>​long: ​   31119751}}))
  
   * [[http://​www.medicalnewstoday.com/​articles/​91894.php|Olmetec Is First Angiotensin Receptor Blocker (ARB) To Suggest Atherosclerosis Regression (in Hypertensives With Cardiovascular Risk)]]   * [[http://​www.medicalnewstoday.com/​articles/​91894.php|Olmetec Is First Angiotensin Receptor Blocker (ARB) To Suggest Atherosclerosis Regression (in Hypertensives With Cardiovascular Risk)]]
home/diseases/cardiovascular.txt · Last modified: 05.24.2019 by sallieq
© 2015, Autoimmunity Research Foundation. All Rights Reserved.